MedPath

A Video Decision Support Tool to Assist Elderly Patients in ESRD Treatment Decision-making

Not Applicable
Completed
Conditions
Decision-making
Chronic Kidney Disease
Interventions
Other: End-stage renal disease treatment options
Registration Number
NCT02698722
Lead Sponsor
Massachusetts General Hospital
Brief Summary

In the United States, it is estimated that there are approximately 630,000 patients who have ESRD with two-thirds of those patients subsequently receiving maintenance dialysis. Studies have demonstrated that the initiation and timing of dialysis for those with ESRD seem to vary widely regionally - confirming the uncertainty of the benefits of chronic dialysis in this population

Pre-dialysis education programs inform patients of all of their options allowing them to choose renal replacement therapy that is most consistent with their wishes. Recent evidence has supported using different methods of delivering education including videos to complement standard clinical care practices to promote informed decision making. This proposed study will serve to examine the efficacy of a dialysis modality video decision support tool to inform chronic kidney disease patients of different dialytic and non-dialytic therapies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • English-speaking during clinical encounters
  • Stage 4 or 5 CKD (defined by the Chronic Kidney Disease Epidemiology Collaboration for estimation of GFR < 30 ml/min/1.73m2)
Exclusion Criteria
  • Known history of dementia
  • Legally blind
  • Listed for kidney transplant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionEnd-stage renal disease treatment optionsThis group will receive the intervention which is a 11.5 minute video about dialysis and non-dialytic therapies.
Primary Outcome Measures
NameTimeMethod
Change in knowledge of end-stage renal disease treatments (hemodialysis vs. peritoneal dialysis vs. supportive care) via surveyChange in knowledge immediately pre and post intervention and at 12 weeks
Secondary Outcome Measures
NameTimeMethod
Change in preference for end-stage renal disease treatment (hemodialysis vs. peritoneal dialysis vs. supportive care) via surveyChange in preferences Immediately pre and post intervention and at 12 weeks

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath